Ferring International SA

New Data Demonstrating Long-term Benefits of FIRMAGON® (degarelix) for Advanced Hormone-dependant Prostate Cancer Published in The Journal of Urology

Contact:

Media enquiries: Orla Barnewell, Tonic Life Communications, Tel:
+44 207 798 9915, orla.barnewell@toniclc.com; Helen Swift, Tonic Life
Communications, Tel: +44 207 798 9924, helen.swift@toniclc.com;
Patrick
Gorman, Ferring Pharmaceuticals, Tel: +41 (0) 58 301 00 53
patrick.gorman@ferring.com



Weitere Meldungen: Ferring International SA

Das könnte Sie auch interessieren: